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Purpose: To describe etiologies and clinical characteristics of corneal opacities leading patients to seek cosmetic 
treatments.
Methods: The medical records of 401 patients who presented for cosmetic improvement in corneal opacities 
between May 2004 and July 2007 were retrospectively reviewed. The following parameters were analyzed: age, 
gender, cause of corneal opacity, time course of the corneal disease, associated diseases, prior and current 
cosmetic treatments, visual acuity, location and depth of the corneal opacity, and the presence of either cor-
neal neovascularization or band keratopathy. A single practitioner examined all patients. 
Results: The most common causes of corneal opacity were ocular trauma (203 eyes, 50.6%), retinal disease (62 
eyes, 15.5%), measles (38 eyes, 9.5%), and congenital etiologies (22 eyes, 5.5%). Prior treatments included iris 
colored contact lenses (125 eyes, 31.1%) and corneal tattooing (34 eyes, 8.46%). A total of 321 of 401 eyes un-
derwent cosmetic treatment for corneal opacities. The most common treatment performed after the primary visit 
was corneal tattooing (261 eyes, 64.92%). 
Conclusions: This is the first study to investigate the causes and clinical characteristics of patients presenting for 
cosmetic treatment of corneal opacities rather than for functional improvement. Various cosmetic interventions 
are available for patients with corneal opacities, and these should be individualized for the needs of each patient. 
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Diseases affecting the cornea are a major cause of blind-
ness worldwide. These diseases can cause corneal scarring 
and neovascularization, which can ultimately lead to func-
tional blindness as well as cosmetic difficulties. The treat-
ments for corneal opacities are divided into functional and 
cosmetic approaches. 
Functional treatments are undertaken for visual improvement 
and include procedures such as corneal transplantation. Due 
to the tremendous progress in microsurgical reconstructive 
procedures and immune suppressive therapies, the success 
rate and indications for corneal transplantation have increased. 
Cosmetic treatments for corneal opacities are currently used 
in a small and carefully selected group of patients in whom 
further surgical procedures will either not result in functional 
improvement or will not carry risks for phthisis; in these pa-
tients cosmetic treatments such as an colored iris contact lens 
[1,2], a scleral shell prosthesis [3], or corneal tattooing 
(keratopigmentation) [4,5]
 may be more appropriate. 
A disfigured cornea can impair an individual’s self-confidence 
and can adversely affect one’s social and professional lives. 
Therefore, ophthalmologists might consider cosmetic repair 
as one of the potential treatment options for corneal opacities 
in carefully selected cases to improve both the patient’s so-
cial relationships and personal sense of well-being. As most 
Asians have dark brown-colored irises, even a small corneal 
opacity can cause significant cosmetic problems. 
As the epidemiology of cosmetic treatments for corneal KC Chang, et al. Corneal Opacities Presenting for Cosmetic Repair
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Fig. 1. A 38-year-old male patient with total corneal opacity and band keratopathy of the left eye (A,B).  Prior to cosmetic treatment (C). One 
year post corneal tattooing (keratopigmentation). 
opacities is not well known, we investigated the causes and 
clinical characteristics of patients who requested cosmetic 
treatment for corneal opacities. 
Materials and Methods
The medical records (including anterior segment photog-
raphy) of 401 patients referred to the Department of 
Ophthalmology, at Seoul National University Hospital for 
the purpose of cosmetic repair of their corneal opacities be-
tween May 2004 and July 2007 were retrospectively reviewed. 
This study included only patients who requested cosmetic 
correction, as opposed to procedures for visual improvement, 
for their corneal opacities. Exclusion criteria included pa-
tients with ongoing curable ocular disease, a history of either 
an alteration in visual acuity or the size of the corneal opacity 
during the past five years, and in whom cosmetic procedures 
may cause additional visual loss, including children under 
eight years of age, in whom intervention may irreversibly af-
fect vision development. The study was performed in accord-
ance with the guidelines of the Declaration of Helsinki. A 
single practitioner (JWK) examined all patients. 
The analyzed parameters included age, gender, cause of 
the corneal opacity, time of onset of corneal disease, asso-
ciated diseases, previous treatments, visual acuity, location 
and depth of the corneal opacity, and the presence of either 
corneal neovascularization or band keratopathy. The loca-
tions of the corneal opacities were divided into two zones 
based on the geographic center of the cornea [6].
 A central 
opacity was defined as being within the central half of the 
cornea. A peripheral opacity was defined as being located in 
the peripheral half of the cornea. A total opacity involved the 
central and more than three quadrants of the peripheral cor-
nea (Fig. 1A). The depth of the opacity was classified as ante-
rior stroma, middle stroma, posterior stroma, or full thick-
ness by a careful slit-lamp examination. Prior (before the first 
visit) and current (after the first visit) cosmetic treatments of 
the corneal opacity were evaluated. Post-treatment follow up 
was performed at one day, one week, one month, three 
months, six months, and one year. Post-treatment assessment 
was performed subjectively by evaluating the patient’s sat-
isfaction with the cosmetic results and objectively by 
slit-lamp biomicroscopy. 
For keratopigmentation, a sterilized tissue-marking dye 
(Davidson Marking System
®; Bradley Products, Inc., Bloomington, 
MN, USA) and a 1 mL syringe with a 30-gauge needle, bevel 
up, were used. After removing the conjunctivalized corneal 
opacities and calcified plaques with a 69 Beaver blade or by 
EDTA chelation immediately before tattooing, the dye was 
injected repeatedly into the corneal stroma until the treated 
area became a dense black color. Then, after irrigating vigo-
rously with a balanced saline solution, a therapeutic contact 
lens was placed on the eye and left in place until the cornea 
had re-epithelized. 
In eyes that had a significant limbal deficiency or a severe 
calcium band, amniotic membrane transplantation was per-
formed with a cryopreserved amniotic membrane in an over-
lay fashion to promote the recovery of the corneal epithelial 
defect.
When a sclera shell was employed, a custom-made, modi-
fied impression-based prosthesis was fabricated using poly 
methyl methacrylate by a trained ocularist.
Results
Among the 401 eyes of the 401 patients examined, 244 Korean J Ophthalmol Vol.24, No.3, 2010
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Table 1. The etiologies of corneal opacities
Etiology Eyes (%)
Trauma 203 (50.6)
Corneal perforation 184 (45.9)
Partial thickness corneal laceration  8 (1.9)
Contusion 5 (1.2)
   Chemical injury  5 (1.2)
   Birth trauma 1 (0.2)
Retinal disease 62 (15.5)
   Retinal detachment  36 (9.0)
   Persistent hyperplastic primary vitreous 11 (2.7)
   Retinopathy of premature 9 (2.2)
   Diabetic retinopathy 2 (0.5)
   Coat’s disease 2 (0.5)
   Acute retinal necrosis 2 (0.5)
Measles   38 (9.5)
Congenital corneal opacity 22 (5.5)
   Congenital glaucoma 4 (1.0)
   Congenital syphilis 1 (0.3)
   Dermoid 6 (1.3)
   Microophthalmia 1 (0.3)
   Unknown 11 (2.7)
Keratitis 23 (5.7)
   Keratouveitis 12 (3.0)
   Herpetic keratitis  7 (1.7)
   Corneal ulcer  4 (1.0)
Cataract surgery 17 (4.2)
Glaucoma 12 (3.0)
Unknown 24 (6.0)
Total 401 (100)
Table 2. Associated ocular findings
Ocular finding Eyes (%)
*
Strabismus 95 (23.6)
 Exotropia 83  (20.6)
   Esotropia 6 (1.5)
   Hypertropia 6 (1.5)
Iris abnormality 77 (19.2)
   Iridocorneal touch 40 (10.0)
   Corectopia 14 (3.5)
   Occlusive pupil 11 (2.7)
   Iris defect 4 (1.0)
   Iris atrophy 3 (0.7)
   Aniridia 2 (0.5)
   Posterior synechia 2 (0.4)
   Incarceration 1 (0.2)
Phthisis 37 (9.2)
Cataract 32 (8.0)
Aphakia 22 (5.5)
Keratoplasty failure 14 (3.5)
Lipid keratopathy 14 (3.5)
End-stage glaucoma 12 (3.0)
Total retinal detachment 7 (1.7)
Megalocornea 6 (1.5)
Nystagmus 3 (0.7)
*Percentage of 401 eyes.
(60.7%) were in men and 157 (39.3%) were in women. The 
proportions of right (n=204, 50.9%) and left (n=197, 49.8%) 
affected eyes was nearly identical. All patients were brown 
eyed. The mean age was 41.64±15.36 years (range, 13 to 80 
years), and the mean age of disease onset was 14.72±15.34 
years (range, 0 to 70 years). The mean duration from onset of 
disease to presentation for corneal opacity treatment was 
26.37±15.04 years (range, 1 to 71 years). The mean fol-
low-up time following cosmetic treatment was 15.7±4.1 
months (range, 12 to 25 months).
The most common causes of the corneal opacities were oc-
ular trauma (203 eyes, 50.6%), retinal disease (62 eyes, 
15.5%), measles (38 eyes, 9.5%), and congenital corneal 
opacities (22 eyes, 5.5%) (Table 1). 
The opacity affected the total cornea in 161 eyes (40.2%) 
and involved a central location in 132 eyes (32.9%) and a pe-
ripheral location in 108 eyes (26.9%). It involved the full- 
thickness of the cornea in 154 eyes (41.4%), the mid-stroma 
in 146 eyes (36.4%), the anterior stroma in 87 eyes (21.7%), 
and the posterior stroma in 14 eyes (3.5%). Associated corneal 
findings included corneal neovascularization in 256 eyes 
(63.7%) and band keratopathy in 187 eyes (46.8%). The fre-
quency of band keratopathy was the lowest in cases with con-
genital corneal opacities and measles-related corneal 
opacities. In contrast, all eyes with persistent hyperplastic 
primary vitreous and retinopathy of prematurity pathologies 
had band keratopathy. 
In the 203 patients with corneal opacities due to ocular 
trauma, the distribution by age at trauma demonstrated that 
69.5% (141 eyes) of patients were aged between 0 to 15 
years, 3.4% (7 eyes) were between 0 and 2 years, 38.9% (79 
eyes) were aged 3 to 6 years, 18.2% (37 eyes) were aged 7 to 
10 years, 8.9% (18 eyes) were aged 11 to 15 years, and 28.6% 
(58 eyes) were aged 15 to 55 years.
The mean frequency of surgical interventions prior to pre-
sentation for a cosmetic intervention was 0.92±1.23 times 
(range, 0 to 9 times). 
Despite the difficulty of intraocular examination secon-
dary to the opacity, the most commonly identified associated 
diseases were strabismus (95 eyes, 23.6%), iris abnormalities 
(77 eyes, 19.2%), phthisis (37 eyes, 9.2%), and cataracts (32 
eyes, 8.0%) (Table 2). 
One hundred fifty-nine of 401 eyes had previously under-
gone cosmetic treatments before the primary visit of this 
study. Prior cosmetic treatments included colored iris con-
tact lenses (125 eyes, 31.2%) and corneal tattooing (34 eyes, 
8.48%). Ninety-four (76%) patients who had previously used 
colored iris contact lenses were unsatisfied with the results, 
and all of the patients (a total of 34 eyes) who had under-KC Chang, et al. Corneal Opacities Presenting for Cosmetic Repair
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Fig. 2. A 49-year-old male patient with a paracentral corneal opacity due to previous corneal injury. Visual acuity was 20/20 in the right eye. 
(A,B) Prior to cosmetic treatment. (C,D) Six months post keratopigmentation. There was no associated visual loss with the cosmetic procedure.
gone prior corneal tattooing complained of fading and 
hypopigmentation. 
Table 3 lists the current cosmetic treatment for corneal 
opacities following the first visit. Three hundred twenty-one 
of 401 eyes underwent further cosmetic treatment after the 
first visit, with the most common treatment being corneal tat-
tooing (261 eyes, 65.1%). Patients who experienced diffi-
culty wearing a colored iris contact lens or scleral shell or 
who were reluctant to have repeated surgery, underwent cor-
neal tattooing as an alternative. Twenty-nine prior users who 
experienced no difficulty wearing colored iris contact lenses 
were asked to continue with this intervention. In four patients 
who were reluctant to have evisceration or enucleation de-
spite significant phthisis,
 a scleral shell was applied. Eighty 
of 401 eyes underwent no cosmetic treatment although an in-
dividualized cosmetic treatment was recommended. 
All eyes that underwent cosmetic treatment achieved the 
desired cosmetic result during a follow-up period of at least 
one year. In particular, no eye that underwent corneal tattoo-
ing demonstrated hypopigmentation, fading, or anterior seg-
ment inflammation (Fig. 1B,C).
The visual acuities of the affected eyes and contra-lateral 
eyes are given in Table 4. Even though the visual acuity of the 
affected eye was greater than 20/400, 24 patients requested a 
cosmetic intervention. These patients had a pupil-sparing 
corneal opacity caused by an open globe injury (8 eyes), 
measles (5 eyes), or a congenital corneal opacity, such as a 
limbal dermoid (4 eyes), herpetic keratitis (3 eyes), surgical 
scar (1 eye), interface opacity of penetrating keratoplasty 
(PKP) (1 eye), or an unknown cause(s) (2 eyes). All of these 
opacities were corrected by corneal tattooing, and there were 
no associated visual losses following the procedures (Fig. 2). 
Fourteen patients with a history of a previous PKP re-
quested cosmetic treatment. None requested additional PKP 
after graft failure due to an irreversible visual loss (due to 
combined glaucoma in seven eyes, post-PKP trauma in one 
eye, and reluctance for repeated surgery in six eyes).
Interestingly, in eight patients, a white pupil secondary to a 
mature cataract caused a more significant cosmetic concern 
than did their corneal opacity.
Discussion
Corneal opacities can cause both severe visual loss as well 
as cosmetic difficulties. The aim of the present study was to 
evaluate the causes and clinical characteristics of patients 
presenting for cosmetic repair of corneal opacities. Here, we 
did not focus on either functional improvement or the effi-Korean J Ophthalmol Vol.24, No.3, 2010
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Table 3. Cosmetic treatments for corneal opacities after the first visit
Treatment Eyes (%)
Tattooing 184 (45.9)
Tattooing+amniotic membrane transplantation  45 (11.2)
Tattooing+calcium removal  23 (5.7)
Tattooing+calcium removal+amniotic membrane transplantation    9 (2.2)
Iris contact lens 56 (14.0)
      Previous users 29  (7.1)
      New users 27 (6.7)
Scleral shell 4 (1.0)
No treatment 80 (20.0)
Total 401 (100)
Table 4. The visual acuities of the affected and contra-lateral eyes. Even though the visual acuity of the affected 
eye was greater than 20/400, 24 patients requested cosmetic intervention. All of these patients had a peripheral 
corneal opacity 
Visual acuity Affected eyes (%) Contra-lateral eyes (%)
No light perception  222 (55.4)   6 (1.5)
Light perception to <20/400 156 (38.9) 17 (4.2)
20/400 to 20/200   3 (0.8)   3 (0.8)
20/100 to 20/60   5 (1.2) 40 (1.0)
20/50 to 20/20 16 (4.0) 336 (83.8)
cacy of the individual cosmetic treatment. 
Ocular trauma was the most common cause of a disfigured 
cornea. The preschool age group (3 to 6 years old) appeared 
to be more susceptible to this type of injury than were the oth-
er age groups. Children in this age group tend to be very ac-
tive and have limited judgment with regard to the potential 
for injury of their activities [7-11]. Pediatric ocular trauma 
can cause not only severe corneal opacities but also can limit 
the opportunities for further treatments, such as PKP, due to 
deprivation of visual development. Many studies have dem-
onstrated that males tend to be injured more frequently than 
females, with the male-to-female ratio varying from 2:1 to 
4:1 [7-11].
 In the current study, we found that 69.5% (141 
eyes) of patients in the traumatic group were between 0 to 15 
years old (of them, 38.9% [79 eyes] were 3 to 6 years old), 
and there was a male-to-female ratio of 2.03:1 (male 136, fe-
male 67). 
Retinal detachment was the second most common cause of 
corneal opacities. These abnormalities may result from cor-
neal decompensation from repeated intraocular surgery 
(mean, 1.95 injuries; range, 0 to 5 injuries), extended contact 
of silicone oil with the cornea (19 eyes, 52.8%), or phthisis 
(especially in five eyes without surgical intervention despite 
retinal detachment). 
Measles was the third most common cause of corneal 
opacity in the current study and is the single leading cause of 
blindness among children in third world countries [12,13].
 
According to World Health Organization estimates, 30 mil-
lion children develop measles every year [12].
 Approximately 
10 to 20% of children with measles require hospitalization 
for related complications, and about 1% of hospitalized chil-
dren subsequently lose their vision [13].
 In the current study, 
the mean age at presentation for corneal opacities due to 
measles was 51 years of age, illustrating that the rate of mea-
sles-related visual impairment in Korea has decreased. In 
fact, there have been few reports of keratopathy caused by 
measles in Korea in recent years. This is likely due to the low 
incidence of active measles strains as a result of widespread 
childhood immunization, improvements in vitamin A-related 
nutrition [14], and improving socioeconomic conditions. The 
major complications of measles-related visual impairment 
are corneal scarring, irido-corneal adhesions, and phthisis 
bulbi [13].
  The current study demonstrated irido-corneal ad-
hesions in ten eyes and phthisis bulbi in one eye. 
Among keratitis-related corneal opacities, the most common 
clinical cause was herpetic keratitis, especially in those with 
a history of uveitis, early onset, or chronic disease recurrence. 
The most common associated disease was sensory stra-
bismus, itself a significant cosmetic problem; 30 patients had 
undergone prior strabismus surgery. 
If fitted and handled properly, colored iris contact lenses 
can be a useful device for treating disfigured eyes [1,2].
 
Improved contact lens technology has diminished the use of 
corneal tattooing. Cosmetic correction with contact lenses is 
reversible and may be more appropriate for patients reluctant 
to have repeated surgeries, including tattooing, and who may 
have a thin cornea (a risk for perforation) or a severe con-
juntivalized cornea (a risk for a poor tattooing result). 
Therefore, we generally recommend colored iris contact 
lenses as the primary therapy for patients having no previous KC Chang, et al. Corneal Opacities Presenting for Cosmetic Repair
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problems related to contact lenses.
While the most common prior cosmetic treatment was the 
use of colored iris contact lenses, the most common treat-
ment in the current study was corneal tattooing. This may be 
due to the fact that many patients enrolled in this study had 
already experienced difficulty wearing contact lenses pre-
viously prescribed at other clinics and did not want to con-
tinue with this treatment modality.
Corneal tattooing has several advantages over colored 
contact lenses [4,5].
 The risk of tattoo-associated corneal in-
fection is limited to the postoperative period, and the cost to 
the patient is only for the initial procedure. Patients also do 
not have to be concerned about contact lens maintenance. For 
patients with peripheral corneal opacities and useful vision, 
corneal tattooing may correct the cosmetic complaint with-
out additional loss of vision, which can be caused by the use 
of colored contact lenses. Therefore, corneal tattooing may 
provide a reasonable cosmetic alternative, especially in pa-
tients who have difficulties wearing colored contact lenses or 
in those with a peripheral corneal opacity and useful vision. 
Of several potential complications of keratopigmentation, 
the discoloration of the impregnated pigment is an un-
common but disconcerting side effect [4,5]. In the current 
study, 34 patients who had previous corneal tattooing at other 
clinics presented for additional cosmetic intervention due to 
discoloration of the pigment. Fortunately, all eyes under-
going corneal tattooing at our clinic had cosmetic staining 
that covered the full opacity area without significant fading 
or hypopigmentation during a follow-up period of at least 
one year. Only two patients had a residual corneal opacity 
following tattooing; this was due to severe calcium plaques 
in the deep stroma. For these cases, a colored iris contact lens 
was prescribed. Corneal tattooing combined with amniotic 
membrane transplantation can be considered for promoting 
recovery of the corneal epithelial defect and for reducing 
post-operative discomfort, especially in eyes with a sig-
nificant limbal deficiency or a severe calcium band.
For the disfigured cornea combined with painless phthisis, 
the fitting of a prosthesis, such as a scleral shell, over the eye 
can be a useful intervention. This can maintain the integrity 
of the orbital anatomy, including fornix volume, enhance ap-
pearance, and accelerate the rehabilitation of patients with a 
disfigured blind eye,
 with the intent of avoiding evisceration 
or
 enucleation [3].
 A scleral shell prosthesis is a thin, hard, 
acrylic shell-like artificial eye designed to be worn over a 
disfigured eye like a contact lens. Compared to an artificial 
eye in anophthalmos, the sclera shell prosthesis has several 
potential advantages [15-17].
 It can move in conjunction 
with eyeball movement, without pegging, and demonstrates 
a superior cosmetic effect. It also has no orbital implant–re-
lated complications such as exposure, infection, or protrusion. 
Moreover, both evisceration and enucleation can change the 
orbital anatomy, including fornix volume and size of the pal-
pebral fissure. In the current study, all four patients who had 
phthisis and who were reluctant to undergo evisceration or 
enucleation achieved the desired cosmetic result with a scler-
al shell.
Our study has several limitations. The reported results are 
probably not applicable to a general ophthalmology practice, 
as cosmetic treatment of corneal opacities is currently ap-
plied to a small and carefully selected group of patients. 
Additionally, these results may not be able to be generalized 
to populations with iris colors that are much more difficult to 
cosmetically match with tattoo dye; all of the patients in the 
current study had brown-colored irises. Also, since this study 
focused on the epidemiology of corneal opacities presenting 
for cosmetic repair and not the efficacy of the cosmetic treat-
ments themselves, choosing the best cosmetic option for the 
various causes and clinical presentations will require further 
studies with larger populations, more outcome data, and lon-
ger follow-up periods.    
To our knowledge, this is the first study to investigate the 
causes of injury and clinical characteristics of patients pre-
senting for cosmetic treatment of corneal opacities. We have 
discussed all available cosmetic treatments for corneal opac-
ities and speculated on which treatment would be most ap-
propriate for each patient group through review of previous 
literature and based on our own experience. The results of 
this study demonstrate that various cosmetic interventions 
are available for patients with corneal opacities, and that 
these should be individualized to each patient. 
Conflict of Interest
No potential conflict of interest relevant to this article was 
reported.
References
  1.Yildirim N, Basmak H, Sahin A. Prosthetic contact lenses: ad-
venture or miracle. Eye Contact Lens 2006;32:102-3.
  2.Cole CJ, Vogt U. Medical uses of cosmetic colored contact 
lenses. Eye Contact Lens 2006;32:203-6.
  3.Raizada K, Rani D. Ocular prosthesis. Cont Lens Anterior Eye 
2007;30:152-62.
  4.Mannis MJ, Eghbali K, Schwab IR. Keratopigmentation: a re-
view of corneal tattooing. Cornea 1999;18:633-7.
  5.Pitz S, Jahn R, Frisch L, et al. Corneal tattooing: an alternative 
treatment for disfiguring corneal scars. Br J Ophthalmol 2002; 
86:397-9.
  6.Rezende RA, Uchoa UB, Uchoa R, et al. Congenital corneal 
opacities in a corneal referral practice. Cornea 2004;23: 
565-70.
  7.LaRoche GR, McIntyre L, Schertzer RM. Epidemiology of se-
vere eye injuries in childhood. Ophthalmology 1988;95:1603-7.
  8.MacEwen CJ, Baines PS, Desai P. Eye injuries in children: the 
current picture. Br J Ophthalmol 1999;83:933-6.
  9.Jandeck C, Kellner U, Bornfeld N, Foerster MH. Open globe 
injuries in children. Graefes Arch Clin Exp Ophthalmol 2000; 
238:420-6.
10.Strahlman E, Elman M, Daub E, Baker S. Causes of pediatric 
eye injuries. A population-based study. Arch Ophthalmol 
1990;108:603-6.
11. Cascairo MA, Mazow ML, Prager TC. Pediatric ocular trau-Korean J Ophthalmol Vol.24, No.3, 2010
154
ma: a retrospective survey. J Pediatr Ophthalmol Strabismus 
1994;31:312-7.
12.WHO-UNICEF joint statement on strategies to reduce mea-
sles mortality worldwide. Wkly Epidemiol Rec 2002;77:224-8.
13.Semba RD, Bloem MW. Measles blindness. Surv Ophthalmol 
2004;49:243-55.
14.Sommer A. Xerophthalmia and vitamin A status. Prog Retin 
Eye Res 1998;17:9-31.
15.Bailey CS, Buckley RJ. Ocular prostheses and contact lenses. 
I-Cosmetic devices. BMJ 1991;302:1010-2.
16.Cote RE, Haddad SE. Fitting a prosthesis over phthisis bulbi 
or discolored blind eyes. Adv Ophthalmic Plast Reconstr Surg 
1990;8:136-45.
17.Lee HY, Yang JW. Clinical analysis of fitting a sclera shell 
over phthisis bulbi or discolored blind eyes. J Korean 
Ophthalmol Soc 2008;49:1041-5.